{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:44:09Z","timestamp":1794656649136,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H05694"],"award-info":[{"award-number":["20H05694"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["JPMJPS2023"],"award-info":[{"award-number":["JPMJPS2023"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Insulin like growth factor-1 (IGF-1) plays important roles in metabolic functions, especially in adulthood. Additionally, obese subjects are reportedly predisposed to having low absolute IGF-1 levels. However, the prevalence and clinical characteristics of obese subjects with low IGF-1 levels are unknown. We examined 64 obese subjects with a body mass index (BMI)\u2009\u2265\u200935\u00a0kg\/m<jats:sup>2<\/jats:sup>, with no history of endocrinological disorders, receiving inpatient care. IGF-1 levels were interpreted based on the IGF-1 standard deviation score (SDS) clinically used and standardized by age and sex (low IGF-1 group;\u2009\u2264\u2009\u2212\u00a02.0 SDS and standard IGF-1 group; \u2212\u00a02.0\u2009&lt;\u2009and\u2009&lt;\u2009\u2009+\u20092.0 SDS). Notably, 26.6% of the subjects had low IGF-1. Body fat mass and percentage, but not BMI, were significantly higher in the low than in the standard IGF-1 group. Furthermore, natural log-transformed high-sensitivity C-reactive protein, and the frequencies of dyslipidemia and hyperuricemia were higher in the low IGF-1 group. Moreover, among the subjects without diabetes, fasting glucose levels were significantly higher in the low IGF-1 group. Stepwise variable selection procedure revealed body fat percentage to be a parameter most strongly associated with low IGF-1. Thus, low IGF-1 levels may be an important marker of adiposity-associated metabolic disorders in obese patients.<\/jats:p>","DOI":"10.1038\/s41598-022-23521-1","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T10:17:34Z","timestamp":1669198654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Insulin-like growth factor-1 levels are associated with high comorbidity of metabolic disorders in obese subjects; a Japanese single-center, retrospective-study"],"prefix":"10.1038","volume":"12","author":[{"given":"Haremaru","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shojiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junro","family":"Seike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junta","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"23521_CR1","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1056\/NEJMra1817346","volume":"380","author":"S Melmed","year":"2019","unstructured":"Melmed, S. Pathogenesis and diagnosis of growth hormone deficiency in adults. N. Engl. J. Med. 380, 2551\u20132562. https:\/\/doi.org\/10.1056\/NEJMra1817346 (2019).","journal-title":"N. Engl. J. Med."},{"key":"23521_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000284355","volume":"73","author":"I Kreitschmann-Andermahr","year":"2010","unstructured":"Kreitschmann-Andermahr, I., Suarez, P., Jennings, R., Evers, N. & Brabant, G. GH\/IGF-I regulation in obesity\u2013mechanisms and practical consequences in children and adults. Horm. Res. Paediatr. 73, 153\u2013160. https:\/\/doi.org\/10.1159\/000284355 (2010).","journal-title":"Horm. Res. Paediatr."},{"key":"23521_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ghir.2014.09.002","volume":"24","author":"S Savastano","year":"2014","unstructured":"Savastano, S., Di Somma, C., Barrea, L. & Colao, A. The complex relationship between obesity and the somatropic axis: The long and winding road. Growth Horm. IGF Res. 24, 221\u2013226. https:\/\/doi.org\/10.1016\/j.ghir.2014.09.002 (2014).","journal-title":"Growth Horm. IGF Res."},{"key":"23521_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0026-0495(94)90099-x","volume":"43","author":"MH Rasmussen","year":"1994","unstructured":"Rasmussen, M. H. et al. The impact of obesity, fat distribution and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone. Metabolism 43, 315\u2013319. https:\/\/doi.org\/10.1016\/0026-0495(94)90099-x (1994).","journal-title":"Metabolism"},{"key":"23521_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/EJE-10-0301","volume":"163","author":"MS Lewitt","year":"2010","unstructured":"Lewitt, M. S. et al. IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women. Eur. J. Endocrinol. 163, 233\u2013242. https:\/\/doi.org\/10.1530\/EJE-10-0301 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"23521_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1507\/endocrj.40.41","volume":"40","author":"H Yamamoto","year":"1993","unstructured":"Yamamoto, H. & Kato, Y. Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults. Endocr. J. 40, 41\u201345. https:\/\/doi.org\/10.1507\/endocrj.40.41 (1993).","journal-title":"Endocr. J."},{"key":"23521_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nrendo.2013.67","volume":"9","author":"RK Junnila","year":"2013","unstructured":"Junnila, R. K., List, E. O., Berryman, D. E., Murrey, J. W. & Kopchick, J. J. The GH\/IGF-1 axis in ageing and longevity. Nat. Rev. Endocrinol. 9, 366\u2013376. https:\/\/doi.org\/10.1038\/nrendo.2013.67 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"23521_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrendo.2018.22","volume":"14","author":"MB Ranke","year":"2018","unstructured":"Ranke, M. B. & Wit, J. M. Growth hormone\u2014Past, present and future. Nat. Rev. Endocrinol. 14, 285\u2013300. https:\/\/doi.org\/10.1038\/nrendo.2018.22 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"23521_CR9","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson, L. et al. Acromegaly: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23521_CR10","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch, M. E. et al. Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1587\u20131609. https:\/\/doi.org\/10.1210\/jc.2011-0179 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23521_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1507\/endocrj.ej12-0110","volume":"59","author":"T Isojima","year":"2012","unstructured":"Isojima, T. et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr. J. 59, 771\u2013780. https:\/\/doi.org\/10.1507\/endocrj.ej12-0110 (2012).","journal-title":"Endocr. J."},{"key":"23521_CR12","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"(NCD-RisC) NRFC","year":"2017","unstructured":"(NCD-RisC) NRFC. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet 390, 2627\u20132642. https:\/\/doi.org\/10.1016\/S0140-6736(17)32129-3 (2017).","journal-title":"Lancet"},{"key":"23521_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s1096-6374(03)00038-8","volume":"13","author":"A Juul","year":"2003","unstructured":"Juul, A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm. IGF Res. 13, 113\u2013170. https:\/\/doi.org\/10.1016\/s1096-6374(03)00038-8 (2003).","journal-title":"Growth Horm. IGF Res."},{"key":"23521_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/gerona\/glaa282","volume":"76","author":"RA Sherlala","year":"2021","unstructured":"Sherlala, R. A. et al. Relationship between serum IGF-1 and BMI differs by age. J. Gerontol. A Biol. Sci. Med. Sci. 76, 1303\u20131308. https:\/\/doi.org\/10.1093\/gerona\/glaa282 (2021).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"23521_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082614","author":"P Juiz-Vali\u00f1a","year":"2020","unstructured":"Juiz-Vali\u00f1a, P. et al. Altered GH-IGF-1 axis in severe obese subjects is reversed after bariatric surgery-induced weight loss and related with low-grade chronic inflammation. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9082614 (2020).","journal-title":"J. Clin. Med."},{"key":"23521_CR16","doi-asserted-by":"publisher","first-page":"e0121087","DOI":"10.1371\/journal.pone.0121087","volume":"10","author":"L Pena-Bello","year":"2015","unstructured":"Pena-Bello, L. et al. Effect of oral glucose administration on rebound growth hormone release in normal and obese women: The role of adiposity, insulin sensitivity and ghrelin. PLoS ONE 10, e0121087. https:\/\/doi.org\/10.1371\/journal.pone.0121087 (2015).","journal-title":"PLoS ONE"},{"key":"23521_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579\u2013591. https:\/\/doi.org\/10.1038\/nrc1408 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"23521_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ecl.2020.02.009","volume":"49","author":"A Hjelholt","year":"2020","unstructured":"Hjelholt, A. et al. Growth hormone and obesity. Endocrinol. Metab. Clin. N. Am. 49, 239\u2013250. https:\/\/doi.org\/10.1016\/j.ecl.2020.02.009 (2020).","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"23521_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13340-021-00562-x","volume":"13","author":"A Sasaki","year":"2022","unstructured":"Sasaki, A. et al. Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: A joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society and the Japan Society for the Study of Obesity. Diabetol. Int. 13, 33\u201334. https:\/\/doi.org\/10.1007\/s13340-021-00562-x (2022).","journal-title":"Diabetol. Int."},{"key":"23521_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41387-022-00217-z","volume":"12","author":"H Lee","year":"2022","unstructured":"Lee, H. et al. Effects of mild obesity on outcomes in Japanese patients with COVID-19: A nationwide consortium to investigate COVID-19 host genetics. Nutr. Diabetes 12, 38. https:\/\/doi.org\/10.1038\/s41387-022-00217-z (2022).","journal-title":"Nutr. Diabetes"},{"key":"23521_CR21","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura, S. et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens. Res. 42, 1235\u20131481. https:\/\/doi.org\/10.1038\/s41440-019-0284-9 (2019).","journal-title":"Hypertens. Res."},{"key":"23521_CR22","first-page":"324","volume":"55","author":"H Yamanaka","year":"2012","unstructured":"Yamanaka, H. & Metabolism, T. G. Essence of the revised guideline for the management of hyperuricemia and gout. Jpn. Med. Assoc. J. 55, 324\u2013329 (2012).","journal-title":"Jpn. Med. Assoc. J."},{"key":"23521_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.5551\/jat.GL2017","volume":"25","author":"M Kinoshita","year":"2018","unstructured":"Kinoshita, M. et al. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J. Atheroscler. Thromb. 25, 846\u2013984. https:\/\/doi.org\/10.5551\/jat.GL2017 (2018).","journal-title":"J. Atheroscler. Thromb."},{"key":"23521_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jdi.13306","volume":"11","author":"E Araki","year":"2020","unstructured":"Araki, E. et al. Japanese clinical practice guideline for diabetes 2019. J. Diabetes Investig. 11, 1020\u20131076. https:\/\/doi.org\/10.1111\/jdi.13306 (2020).","journal-title":"J. Diabetes Investig."},{"key":"23521_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KCJ Yuen","year":"2019","unstructured":"Yuen, K. C. J. et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr. Pract. 25, 1191\u20131232. https:\/\/doi.org\/10.4158\/GL-2019-0405 (2019).","journal-title":"Endocr. Pract."},{"key":"23521_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/eje.1.01829","volume":"152","author":"PE Clayton","year":"2005","unstructured":"Clayton, P. E. et al. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur. J. Endocrinol. 152, 165\u2013170. https:\/\/doi.org\/10.1530\/eje.1.01829 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"23521_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS Ellulu","year":"2017","unstructured":"Ellulu, M. S., Patimah, I., Khaza\u2019ai, H., Rahmat, A. & Abed, Y. Obesity and inflammation: The linking mechanism and the complications. Arch. Med. Sci. 13, 851\u2013863. https:\/\/doi.org\/10.5114\/aoms.2016.58928 (2017).","journal-title":"Arch. Med. Sci."},{"key":"23521_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 127, 1\u20134. https:\/\/doi.org\/10.1172\/JCI92035 (2017).","journal-title":"J. Clin. Investig."},{"key":"23521_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.beem.2015.07.002","volume":"29","author":"A Hoeflich","year":"2015","unstructured":"Hoeflich, A. & Russo, V. C. Physiology and pathophysiology of IGFBP-1 and IGFBP-2\u2014Consensus and dissent on metabolic control and malignant potential. Best Pract. Res. Clin. Endocrinol. Metab. 29, 685\u2013700. https:\/\/doi.org\/10.1016\/j.beem.2015.07.002 (2015).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"23521_CR30","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1210\/jcem.85.4.6541","volume":"85","author":"N Mauras","year":"2000","unstructured":"Mauras, N. et al. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: Differential effects on protein, glucose, lipid and calcium metabolism. J. Clin. Endocrinol. Metab. 85, 1686\u20131694. https:\/\/doi.org\/10.1210\/jcem.85.4.6541 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23521_CR31","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1172\/JCI117427","volume":"94","author":"MA Hussain","year":"1994","unstructured":"Hussain, M. A. et al. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J. Clin. Investig. 94, 1126\u20131133. https:\/\/doi.org\/10.1172\/JCI117427 (1994).","journal-title":"J. Clin. Investig."},{"key":"23521_CR32","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1210\/jcem.86.4.7377","volume":"86","author":"AL Friedlander","year":"2001","unstructured":"Friedlander, A. L. et al. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J. Clin. Endocrinol. Metab. 86, 1496\u20131503. https:\/\/doi.org\/10.1210\/jcem.86.4.7377 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23521_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ghir.2004.12.003","volume":"15","author":"N Mauras","year":"2005","unstructured":"Mauras, N. & Haymond, M. W. Are the metabolic effects of GH and IGF-I separable?. Growth Horm. IGF Res. 15, 19\u201327. https:\/\/doi.org\/10.1016\/j.ghir.2004.12.003 (2005).","journal-title":"Growth Horm. IGF Res."},{"key":"23521_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/j.1550-8528.1996.tb00256.x","volume":"4","author":"S Yang","year":"1996","unstructured":"Yang, S., Bj\u00f6rntorp, P., Liu, X. & Ed\u00e9n, S. Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of beta-adrenergic receptors in adipocytes: No differences in the effects of growth hormone on different fat depots. Obes. Res. 4, 471\u2013478. https:\/\/doi.org\/10.1002\/j.1550-8528.1996.tb00256.x (1996).","journal-title":"Obes. Res."},{"key":"23521_CR35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrendo.2013.64","volume":"9","author":"DE Berryman","year":"2013","unstructured":"Berryman, D. E., Glad, C. A., List, E. O. & Johannsson, G. The GH\/IGF-1 axis in obesity: Pathophysiology and therapeutic considerations. Nat. Rev. Endocrinol. 9, 346\u2013356. https:\/\/doi.org\/10.1038\/nrendo.2013.64 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"23521_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","volume":"14","author":"GA Aguirre","year":"2016","unstructured":"Aguirre, G. A., De Ita, J. R., de la Garza, R. G. & Castilla-Cortazar, I. Insulin-like growth factor-1 deficiency and metabolic syndrome. J. Transl. Med. 14, 3. https:\/\/doi.org\/10.1186\/s12967-015-0762-z (2016).","journal-title":"J. Transl. Med."},{"key":"23521_CR37","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.molmet.2021.101245","volume":"52","author":"D LeRoith","year":"2021","unstructured":"LeRoith, D., Holly, J. M. P. & Forbes, B. E. Insulin-like growth factors: Ligands, binding proteins and receptors. Mol. Metab. 52, 101245. https:\/\/doi.org\/10.1016\/j.molmet.2021.101245 (2021).","journal-title":"Mol. Metab."},{"key":"23521_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","volume":"57","author":"DR Clemmons","year":"2011","unstructured":"Clemmons, D. R. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin. Chem. 57, 555\u2013559. https:\/\/doi.org\/10.1373\/clinchem.2010.150631 (2011).","journal-title":"Clin. Chem."},{"key":"23521_CR39","doi-asserted-by":"publisher","first-page":"683250","DOI":"10.3389\/fmed.2021.683250","volume":"8","author":"V Marques","year":"2021","unstructured":"Marques, V. et al. Adiponectin, leptin and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD. Front. Med. 8, 683250. https:\/\/doi.org\/10.3389\/fmed.2021.683250 (2021).","journal-title":"Front. Med."},{"key":"23521_CR40","doi-asserted-by":"publisher","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"Stanley, T. L. et al. Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 106, e520\u2013e533. https:\/\/doi.org\/10.1210\/clinem\/dgaa792 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"23521_CR41","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982\u2013992. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"23521_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883 (1985).","journal-title":"Diabetologia"},{"key":"23521_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2009.01.046","volume":"206","author":"A Tokita","year":"2009","unstructured":"Tokita, A. et al. Carotid arterial elasticity is a sensitive atherosclerosis value reflecting visceral fat accumulation in obese subjects. Atherosclerosis 206, 168\u2013172. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.01.046 (2009).","journal-title":"Atherosclerosis"},{"key":"23521_CR44","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.amjhyper.2006.05.010","volume":"19","author":"T Yanase","year":"2006","unstructured":"Yanase, T. et al. Evaluation of a new carotid intima-media thickness measurement by B-mode ultrasonography using an innovative measurement software, intimascope. Am. J. Hypertens. 19, 1206\u20131212. https:\/\/doi.org\/10.1016\/j.amjhyper.2006.05.010 (2006).","journal-title":"Am. J. Hypertens."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23521-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T10:26:25Z","timestamp":1669199185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23521-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23521"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23521-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20130"}}